Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Genetic Technologies stock
Learn how to easily invest in Genetic Technologies stock.
Genetic Technologies Ltd is a diagnostics & research business based in the US. Genetic Technologies shares (GENE) are listed on the NASDAQ and all prices are listed in US Dollars. Genetic Technologies employs 52 staff and has a trailing 12-month revenue of around $9.2 million.
How to buy shares in Genetic Technologies
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GENE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Genetic Technologies stock price (NASDAQ: GENE)Use our graph to track the performance of GENE stocks over time.
Genetic Technologies shares at a glance
|Latest market close||$1.24|
|52-week range||$0.95 - $3.27|
|50-day moving average||$1.50|
|200-day moving average||$1.66|
|Wall St. target price||$12.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.60|
Buy Genetic Technologies shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Genetic Technologies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Genetic Technologies price performance over time
|1 week (2022-09-23)||-4.62%|
|1 month (2022-08-26)||N/A|
|3 months (2022-06-28)||-3.88%|
|6 months (2022-03-26)||N/A|
|1 year (2021-09-30)||-59.87%|
|2 years (2020-09-30)||-64.16%|
|3 years (2019-09-30)||1.9|
|5 years (2017-09-29)||45.92%|
Genetic Technologies financials
|Revenue TTM||$9.2 million|
|Gross profit TTM||$6.2 million|
|Return on assets TTM||-21.54%|
|Return on equity TTM||-37.57%|
|Market capitalisation||$21.5 million|
TTM: trailing 12 months
Genetic Technologies share dividends
We're not expecting Genetic Technologies to pay a dividend over the next 12 months.
Have Genetic Technologies's shares ever split?
Genetic Technologies's shares were split on a 1:4 basis on 14 August 2019. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Genetic Technologies shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Genetic Technologies shares which in turn could have impacted Genetic Technologies's share price.
Genetic Technologies share price volatility
Over the last 12 months, Genetic Technologies's shares have ranged in value from as little as $0.95 up to $3.27. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genetic Technologies's is 1.282. This would suggest that Genetic Technologies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Genetic Technologies overview
Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, and type 2 diabetes. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom.
Genetic Technologies in the news
Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer
Genetic Technologies Provides Update on US Operations and Payer Engagement
Frequently asked questionsWhat percentage of Genetic Technologies is owned by institutions?
Currently 1.44% of Genetic Technologies shares are held by institutions. How many people work for Genetic Technologies?
Latest data suggests 52 work at Genetic Technologies. When does the fiscal year end for Genetic Technologies?
Genetic Technologies's fiscal year ends in June. Where is Genetic Technologies based?
Genetic Technologies's address is: 60-66 Hanover Street, Fitzroy, VIC, Australia, 3065 What is Genetic Technologies's ISIN number?
Genetic Technologies's international securities identification number is: US37185R3075 What is Genetic Technologies's CUSIP number?
Genetic Technologies's Committee on Uniform Securities Identification Procedures number is: 37185R109
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert